SCHEMBL8319230

SCHEMBL8319230

CC(=O)OC[C@H]1CCc2c(cc3ccccn23)C1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SLC18A3 Q16572 2/20 0.35
PTGIR P43119 1/20 0.34
BCHE P06276 3/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
S1PR1 P21453 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
MAPT P10636 2/20 0.32
MCHR1 Q99705 1/20 0.31
AHR P35869 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6015851 1.00 HTT (0.38) HTTATML3MBTL1SLC18A3PTGIR
SCHEMBL9384486 0.88 SLC18A3 (0.39) HTTATML3MBTL1SLC18A3PTGIR
SCHEMBL9386696 0.84 MTNR1A (0.36) MAPTMCHR1
SCHEMBL1999145 0.81 BUB1 (0.32) HTTATML3MBTL1S1PR1
SCHEMBL8449850 0.80 DGAT1 (0.45) PTGIRALDH1A1MAPTPOLB
SCHEMBL1991216 0.79 GBA1 (0.33) HTTATML3MBTL1NPC1RAB9A
SCHEMBL8324468 0.79 GBA1 (0.33) HTTATML3MBTL1NPC1RAB9A
SCHEMBL9384846 0.79 SLC18A3 (0.36) HTTATML3MBTL1SLC18A3PTGIR
SCHEMBL1998038 0.77 FKBP1A (0.32)
SCHEMBL9387801 0.77 SLC6A2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0574783-B1 Asymmetric hydrogenation HOFFMANN LA ROCHE (CH) 1999-10-06 EP disclosed
EP-0540956-B1 Process for the manufacture of substituted maleimides HOFFMANN LA ROCHE (CH) 1997-09-03 EP disclosed
US-5399712-A Protein kinase C inhibitor HOFFMANN-LA ROCHE INC. (US) 1995-03-21 US disclosed
EP-0540956-A1 Process for the manufacture of substituted maleimides F. HOFFMANN-LA ROCHE AG (CH) 1993-05-12 EP disclosed